The latest report titled Global Liquid Biopsy Market by Emergen Research involves meticulous research on the global Liquid Biopsy business space, expanding on the latest industry trends, worldwide market growth, market size & share, key drivers and opportunities, constraining factors, product segmentation, cost structure, market volume, competitive terrain, product portfolios and specifications, and company profiles. The report is a prototype of the thorough investigation of the Liquid Biopsy market and serves as a valuable source of data and information pertaining to the market.
Development of liquid biopsy has led to a better understanding of molecular diagnostics of circulating tumor DNA. Increased adoption of liquid biopsy in cancer is due to its potential of non-invasive detection of targeted genomic alteration in correspondence to targeted therapy. Non-cancerous application of liquid biopsy includes diagnosis of heart attack, and atherosclerosis. Advancements in next-generation sequencing for patients with advanced stages of cancer is also driving market growth.
Get a PDF sample copy of this report @ https://www.emergenresearch.com/request-sample/34
Key Highlights From The Report
- The therapy selection for metastatic breast cancer application is the major contributor to the Liquid Biopsy Market. The therapy selection for metastatic breast cancer application of the North America region is the major shareholder of the market and held around 41.9% of the market in the year 2019.
- North America dominated the market for Liquid Biopsy in 2019. The region’s consistent focus on cost-effective and innovative procedures that are adopted in the area is driving the market. The North America region held approximately 51.2% of the market, followed by Europe, which contains around 25.0% market in the year 2019.
- Key participants include RainDance Technologies, Personal Genome Diagnostics, Adaptive Biotechnologies, NeoGenomics Laboratories, Guardant Health, Cynvenio, Biocept, Qiagen, Trovagene, and F. Hoffmann-La Roche Ltd., among others.
Liquid Biopsy Market Segmentation:
For the purpose of this report, Emergen Research has segmented the global Liquid Biopsy Market on the basis of Sample Type, Technology, Application, and region:
- Sample Type Outlook (Revenue, USD Billion; 2017-2027)
- Blood Sample-based
- Urine Sample-based
- Other Bio Fluids-based
- Technology Outlook (Revenue, USD Billion; 2017-2027)
- Multi-gene-parallel Analysis (NGS)
- Single Gene Analysis (PCR Microarrays)
- Application Outlook (Revenue, USD Billion; 2017-2027)
- Therapy Selection for Metastatic Breast Cancer
- Therapy Selection for Other Metastatic Cancer
- Molecular Health Monitoring
The report offers insights into the demands for the Liquid Biopsy products in the global market, especially in the key geographical regions where the market has established its presence. These key regions include North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.For a comprehensive understanding of the market, the vertical is further segmented into product types offered by the market, application spectrum, and end-user industries, among others. It also offers information on the leading manufacturers and vendors in the key geographical regions of the industry.
Request customization of the report @ https://www.emergenresearch.com/request-for-customization/34
Focal Points of the Global Liquid Biopsy Market Report:
- Market Coverage: This section of the report covers significant details on the key manufacturers, vital market segments, product innovation scope, and the forecast years. Additionally, it describes in detail the range of the product and the global Liquid Biopsymarket segmentation based on product type and application spectrum.
- Executive Summary: In this chapter, the global market growth rate, competitive landscape, drivers and constraints, trends, limitations, and the key market segments have been discussed at length.
- Regional Analysis: The report offers meaningful insights into the import and export trends, production and consumption capacities, estimated revenue share, and key players of each region dominating the market
- Competitive Landscape:The report also discusses the course of development of each market player in this industry vertical during the forecast period. It further details on the firms, industries, organizations, vendors, and local manufacturers engaged in this industry. The leading products and services to gain global and regional market shares form the competitive landscape of the Liquid Biopsy industry.
- Manufacturers’ portfolios: This section includes detailed information regarding the product portfolio of each local and global manufacturer, their strengths and weaknesses, product profiles, production value and capacity, and other vital information.
Table Of Content:
Chapter 1. Methodology & Sources
1.1. Market Definition
1.2. Research Scope
1.3. Methodology
1.4. Research Sources
1.4.1. Primary
1.4.2. Secondary
1.4.3. Paid Sources
1.5. Market Estimation Technique
Chapter 2. Executive Summary
2.1. Summary Snapshot, 2019-2027
Chapter 3. Key Insights
Chapter 4. Liquid Biopsy Market Segmentation & Impact Analysis
4.1. Liquid Biopsy Market Material Segmentation Analysis
4.2. Industrial Outlook
4.2.1. Market indicators analysis
4.2.2. Market drivers analysis
4.2.2.1. Rising application of liquid biopsy due to increasing prevalence of cancers
4.2.2.2. Growing interest in liquid biopsy
4.2.3. Market restraints analysis
4.2.3.1. Unclear reimbursement and regulatory scenario associated with liquid biopsy
4.3. Technological Insights
4.4. Regulatory Framework
4.5. Porter’s Five Forces Analysis
4.6. Competitive Metric Space Analysis
4.7. Price trend Analysis
4.8. Covid-19 Impact Analysis
READ MORE…!
Get a broad analysis of the COVID19 impact on the Liquid Biopsy market @ https://www.emergenresearch.com/industry-report/liquid-biopsy-market
Thank you for reading our report. For further inquiry about customization, kindly get in touch with us, and our team will make sure the report is best suited for your needs.
Read similar reports by Emergen Research:
Clinical Perinatal Software Market@ https://www.google.co.jp/url?q=https://www.emergenresearch.com/industry-report/clinical-perinatal-software-market
Nanopharmaceutical Drugs Market@ https://www.google.co.je/url?q=https://www.emergenresearch.com/industry-report/nanopharmaceutical-drugs-market
Cloud Billing Market@ https://www.google.jo/url?q=https://www.emergenresearch.com/industry-report/cloud-billing-market
Medical Supplies Market@ https://www.google.kz/url?q=https://www.emergenresearch.com/industry-report/medical-supplies-market
Antimicrobial Susceptibility Testing/ Antibiotic Sensitivity Testing Market@ https://www.google.co.ke/url?q=https://www.emergenresearch.com/industry-report/antimicrobial-susceptibility-testing-market
About Emergen Research
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: [email protected]
